Literature DB >> 23050057

Thermodynamic Investigation of Inhibitor Binding to 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase.

Guobin Cai1, Lisheng Deng, Bartlomiej G Fryszczyn, Nicholas G Brown, Zhen Liu, Hong Jiang, Timothy Palzkill, Yongcheng Song.   

Abstract

Isothermal titration calorimetry (ITC) was used to investigate the binding of six inhibitors to 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR), a target for developing novel anti-infectives. The binding of hydroxamate inhibitors to E. coli DXR is Mg(2+)-dependent, highly endothermic (ΔH: 22.7-24.3 kJ/mol) and entropy-driven, while that of non-hydroxamate compounds is metal ion independent and exothermic (ΔH: -19.4- -13.8 kJ/mol), showing hydration/dehydration of the enzyme metal ion binding pocket account for the drastic ΔH change. However, for DXRs from Plasmodium falciparum and Mycobacterium tuberculosis, the binding of all inhibitors is exothermic (ΔH: -24.9 - -9.2 kJ/mol), suggesting the metal ion binding sites of these two enzymes are considerably less hydrated. The dissociation constants measured by ITC are well correlated with those obtained by enzyme inhibition assays (R(2) = 0.75). Given the rapid rise of antibiotic resistance, this work is of interest since it provides novel structural implications for rational development of potent DXR inhibitors.

Entities:  

Year:  2012        PMID: 23050057      PMCID: PMC3462030          DOI: 10.1021/ml300071w

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  27 in total

1.  Crystal structure of 1-deoxy-D-xylulose 5-phosphate reductoisomerase complexed with cofactors: implications of a flexible loop movement upon substrate binding.

Authors:  Shunsuke Yajima; Takamasa Nonaka; Tomohisa Kuzuyama; Haruo Seto; Kanju Ohsawa
Journal:  J Biochem       Date:  2002-03       Impact factor: 3.387

Review 2.  The non-mevalonate pathway of isoprenoid precursor biosynthesis.

Authors:  William N Hunter
Journal:  J Biol Chem       Date:  2007-04-18       Impact factor: 5.157

3.  Chimeras of two isoprenoid synthases catalyze all four coupling reactions in isoprenoid biosynthesis.

Authors:  Hirekodathakallu V Thulasiram; Hans K Erickson; C Dale Poulter
Journal:  Science       Date:  2007-04-06       Impact factor: 47.728

Review 4.  Adding calorimetric data to decision making in lead discovery: a hot tip.

Authors:  John E Ladbury; Gerhard Klebe; Ernesto Freire
Journal:  Nat Rev Drug Discov       Date:  2009-12-04       Impact factor: 84.694

5.  Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.

Authors:  Steffen Borrmann; Ingrid Lundgren; Sunny Oyakhirome; Bénido Impouma; Pierre-Blaise Matsiegui; Ayola A Adegnika; Saadou Issifou; Jürgen F J Kun; David Hutchinson; Jochen Wiesner; Hassan Jomaa; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

6.  Structural basis of fosmidomycin action revealed by the complex with 2-C-methyl-D-erythritol 4-phosphate synthase (IspC). Implications for the catalytic mechanism and anti-malaria drug development.

Authors:  Stefan Steinbacher; Johannes Kaiser; Wolfgang Eisenreich; Robert Huber; Adelbert Bacher; Felix Rohdich
Journal:  J Biol Chem       Date:  2003-03-05       Impact factor: 5.157

7.  The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation.

Authors:  Aengus Mac Sweeney; Roland Lange; Roberta P M Fernandes; Henk Schulz; Glenn E Dale; Alice Douangamath; Philip J Proteau; Christian Oefner
Journal:  J Mol Biol       Date:  2005-01-07       Impact factor: 5.469

8.  A 1-deoxy-D-xylulose 5-phosphate reductoisomerase catalyzing the formation of 2-C-methyl-D-erythritol 4-phosphate in an alternative nonmevalonate pathway for terpenoid biosynthesis.

Authors:  S Takahashi; T Kuzuyama; H Watanabe; H Seto
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

Review 9.  The MEP pathway: a new target for the development of herbicides, antibiotics and antimalarial drugs.

Authors:  M Rodríguez-Concepción
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 10.  Do enthalpy and entropy distinguish first in class from best in class?

Authors:  Ernesto Freire
Journal:  Drug Discov Today       Date:  2008-08-26       Impact factor: 7.851

View more
  5 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  Antimalarial and Structural Studies of Pyridine-containing Inhibitors of 1-Deoxyxylulose-5-phosphate Reductoisomerase.

Authors:  Jian Xue; Jiasheng Diao; Guobin Cai; Lisheng Deng; Baisong Zheng; Yuan Yao; Yongcheng Song
Journal:  ACS Med Chem Lett       Date:  2013-02-14       Impact factor: 4.345

3.  Expression, characterization and inhibition of Toxoplasma gondii 1-deoxy-D-xylulose-5-phosphate reductoisomerase.

Authors:  Guobin Cai; Lisheng Deng; Jian Xue; Silvia N J Moreno; Boris Striepen; Yongcheng Song
Journal:  Bioorg Med Chem Lett       Date:  2013-01-30       Impact factor: 2.823

4.  Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.

Authors:  Justin L Anglin; Lisheng Deng; Yuan Yao; Guobin Cai; Zhen Liu; Hong Jiang; Gang Cheng; Pinhong Chen; Shuo Dong; Yongcheng Song
Journal:  J Med Chem       Date:  2012-09-06       Impact factor: 7.446

5.  Alteration of the flexible loop in 1-deoxy-D-xylulose-5-phosphate reductoisomerase boosts enthalpy-driven inhibition by fosmidomycin.

Authors:  Svetlana A Kholodar; Gregory Tombline; Juan Liu; Zhesen Tan; C Leigh Allen; Andrew M Gulick; Andrew S Murkin
Journal:  Biochemistry       Date:  2014-05-22       Impact factor: 3.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.